Succinylpurines do not modify glutamate or adenosine effects in the CNS.
Stone
T W
TW
Division of Neuroscience and Biomedical Systems, University of Glasgow, Scotland.
Duley
J A
JA
Simmonds
H A
HA
Vincent
M F
MF
van den Berghe
G
G
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D005071:Evoked Potentials / Q000187:drug effects; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects*; D018698:Glutamic Acid / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007608:Kainic Acid / Q000494:pharmacology; D051381:Rats; D012263:Ribonucleosides / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*
D012263:Ribonucleosides; C043566:succinylaminoimidazole carboxamide riboside; D000620:Aminoimidazole Carboxamide; D018698:Glutamic Acid; C043565:succinyladenosine; D000241:Adenosine; D007608:Kainic Acid